Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Omnicell To Present At The 36th Annual J.P. Morgan Healthcare Conference

Posted on: 17 Dec 17

MOUNTAIN VIEW, Calif., Dec. 14, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the 36th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, San Francisco, CA. 

Omnicell Speakers: Randall A. Lipps, chairman, president, CEO & founder and Peter Kuipers, executive vice president & CFO

Date: Thursday, January 11, 2018
Time: 8:30 a.m. PT – Presentation
9:00 a.m. PT – Q&A
Location: Westin St. Francis Hotel, San Francisco, CA
Availability: The audio-webcast of the live presentation may be accessed by visiting:

Following the conference, a replay of the audio-webcast will be archived for 30 days on the Omnicell website.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.

Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.

For more information about Omnicell, Inc. please visit

Editor's Details

Mike Wood

Last updated on: 17/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.